Lucy Scientific Discovery Acquires BlueSky Wellness

cbdMD Acquires Substantially All Assets of Bluebird Botanicals

January 29, 2026

Consumer Products

cbdMD, Inc. (NYSE American: YCBD) acquired substantially all assets of Bluebird Botanicals in early January 2026 to integrate Bluebird's regulatory science, safety and IP assets into cbdMD's clinical and toxicology platform. The deal strengthens cbdMD's regulatory-compliance and GRAS capabilities for both broad-spectrum and full-spectrum cannabinoid formulations and is expected to contribute to revenue growth and expanded product safety dossiers.

Blue Water Ventures International Acquires Psycheceutical, Inc.

January 20, 2022

Biotechnology

Blue Water Ventures International, Inc. (BWVI) has completed a merger to acquire Psycheceutical, Inc., making the biotech a wholly-owned subsidiary. BWVI — a publicly-listed company — will pivot its business to focus on psychedelic drug development and intends to provide near-term capital as Psycheceutical advances its delivery technologies toward initial clinical trials.

LDC-backed Lucid Group Acquires Bluedog

February 14, 2019

Marketing & Advertising

LDC-backed Lucid Group has acquired creative and digital consultancy Bluedog to add digital design, motion graphics, video and web development capabilities to its medical communications offering. The deal is Lucid Group’s first acquisition under its LDC partnership and is intended to broaden the Group’s creative and digital capability to better engage healthcare audiences.

Momentive Software Acquires Blue Sky eLearn

February 10, 2025

Software

Momentive Software acquired Blue Sky eLearn to expand its learning management solutions for associations and mission-driven organizations. The acquisition adds Blue Sky’s Path LMS (used by over three million users across ~400 organizations) to Momentive’s cloud-based portfolio; terms were not disclosed.

OTC Markets Group Acquires Blue Sky Data Corp Assets

March 17, 2022

Data & Analytics

OTC Markets Group Inc. signed a definitive agreement to acquire the assets of Blue Sky Data Corp, a provider of state "Blue Sky" securities compliance data, with the transaction expected to close in early May 2022. The acquisition expands OTC Markets' Blue Sky data offering to enhance compliance tools for broker-dealers, financial advisors, public companies and regulators.

Delic Holdings Inc. Acquires Complex Biotech Discovery Ventures Ltd.

May 27, 2021

Biotechnology

Delic Holdings Inc. (DELIC), a publicly traded psychedelic wellness platform based in Vancouver, has acquired all issued and outstanding shares of Complex Biotech Discovery Ventures Ltd. (CBDV), a Vancouver-based licensed psilocybin and cannabis research laboratory, for a closing payment of $7.0 million plus up to $3.0 million of earn-out consideration. CBDV will be rebranded as DELIC Labs and will serve as Delic's R&D and IP engine for psilocybin and cannabis extraction, analytical testing, and chemical process development.